Life Sciences

The firm regularly advises life-sciences companies that require restructuring at various stages of their development—from innovative biotechnology startups to global medical device companies, as well as hospitals and other healthcare-related entities. The firm’s deep intellectual property expertise bolsters work with these companies in both out-of-court and in-court restructurings; we also represent buyers of assets and official committees of unsecured creditors in connection with life-science restructurings. 

Here are a few of our representations:

Our website uses cookies to enhance site navigation, analyze site usage, and assist in our marketing efforts. By continuing to browse this website, you agree to our Privacy Policy.